Trevi Therapeutics to Host Conference Call and Webcast on June 2nd to Share Topline Results from the Phase 2b CORAL Trial of Haduvio in Patients with Idiopathic Pulmonary Fibrosis Chronic Cough
NEW HAVEN, Conn., June 1, 2025 /PRNewswire/ — Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and in patients with refractory chronic cough (RCC), today announced a conference call and live webcast taking place tomorrow, Monday, June 2nd, 2025, at 8:30 a.m. ET, to share topline results from the Phase 2b CORAL trial of Haduvio in patients with IPF chronic cough.
Conference Call/WebcastThe Company will host a conference call and webcast to review the topline results. The live webcast, including audio and presentation slides, will be accessible at the time of the meeting and can be accessed here. To participate in the live conference call by phone, please dial (877) 870 4263 (domestic) or (412) 317 0790 (international) and ask to join the Trevi Therapeutics call. No code is necessary for access. An archived replay of the webcast will also be available for 30 days on the Company's website following the event.
About Idiopathic Pulmonary Fibrosis (IPF) Chronic CoughChronic cough is a highly prevalent condition in patients with IPF, impacting up to 85% of the IPF population. There are ~140,000 patients in the U.S. with IPF. The impact of chronic cough is significant with patients coughing up to 1,500 times per day. This consistent cough and any associated damage may lead to worsening disease, a higher risk of progression, death, or need for lung transplant. Chronic cough also often leads to a decline in patients' social, physical, and psychological quality of life. There are no approved therapies for the treatment of chronic cough in patients with IPF and current off-label treatment options provide minimal benefit to patients.
About Trevi Therapeutics, Inc. Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine extended-release) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and in patients with refractory chronic cough (RCC). Haduvio is the first and only investigational therapy to show a statistically-significant reduction in cough frequency in clinical trials of patients with IPF chronic cough and in patients with RCC. Haduvio acts on the cough reflex arc both centrally and peripherally as a kappa agonist and a mu antagonist (KAMA), targeting opioid receptors that play a key role in controlling chronic cough. Nalbuphine is not currently scheduled by the U.S. Drug Enforcement Agency.
Trevi intends to propose Haduvio as the trade name for oral nalbuphine ER. Its safety and efficacy have not been evaluated by any regulatory authority.
For more information, visit www.TreviTherapeutics.com and follow Trevi on X (formerly Twitter) and LinkedIn.
Investor ContactJonathan CarlsonTrevi Therapeutics, Inc.(203) 654 3286carlsonj@trevitherapeutics.com
Media ContactRosalia Scampoli914-815-1465rscampoli@marketcompr.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
3 days ago
- Malaysian Reserve
Children's Hospital of Philadelphia and Children's Hospital Colorado Researchers Conduct First Prospective Study of Pediatric EoE Patients and Disease Progression
Study found that stiffness of the esophagus could serve as an important biomarker for disease progression and indicate which patients may benefit the most from current therapies PHILADELPHIA, Aug. 15, 2025 /PRNewswire/ — Researchers from Children's Hospital of Philadelphia (CHOP) and Children's Hospital Colorado have found that better control of chronic eosinophilic esophagitis (EoE)-associated inflammation during childhood leads to less stiffening of the esophagus, resulting in fewer disease complications. Using Endoluminal functional imaging (FLIP), the study team suggests this could be a key marker for assessing disease severity and progression. The findings were published online today by the journal Gastroenterology. EoE is a chronic allergic inflammatory disease of the esophagus, the muscular tube that carries food from the throat to the stomach. Children can experience nausea, regurgitation, vomiting, abdominal pain and a burning feeling like acid reflux. They may also have difficulty swallowing and gag frequently. Often, they can experience dysphagia, which is when it feels like something is stuck in their throat. If EoE goes untreated, the esophagus may narrow because of scarring, a phenomenon known as stricture. Chronic EoE-associated inflammation can lead to progressive tissue remodeling and fibrostenosis, or the narrowing of the esophagus. While clinicians recognize the severity of the disease, long-term studies looking at disease progression over time, and the impact of controlling the disease from a young age, is relatively unknown. 'This is the first study to follow kids overtime (with these endoscopic assessments) and evaluate the patients who are at the highest risk of complications,' said co-senior study author Amanda Muir, MD, a pediatric gastroenterologist in the Division of Gastroenterology, Hepatology and Nutrition at CHOP. 'With the recent FDA approval of two medications for EoE, having this data could help identify the patients who could benefit from these therapies the most and observe improvement at a histologic level over time.' Researchers at CHOP and Children's Hospital Colorado launched a longitudinal study to evaluate long-term changes in esophageal distensibility, or the ability of the esophagus to expand, in pediatric patients between the ages of 3 and 18 years old. Symptomatic, endoscopic and histologic data were collected at each visit during the study. A total of 112 patients with EoE were included with a median follow-up time of 11 months, some followed for over 4 years. 'Following children living with EoE over time has given us a clearer picture of how inflammation affects the esophagus and how treating it can improve the esophagus and outcomes for patients,' said Calies Menard-Katcher, MD, co-senior study author and Associate Director of Clinical Research for the Gastrointestinal Eosinophilic Diseases Program at Children's Hospital Colorado. 'It's exciting to see these results confirm what we've suspected in caring for patients — and they may even help us spot those at risk for more severe disease.' The study found that patients with tissue samples showing a response to treatment demonstrated the most improvement in distensibility over time. After adjusting for different factors, the study found that patients with lower esophageal distensibility had increased odds of patient-reported dysphagia, or difficulty swallowing. Patients with fibrostenosis were generally diagnosed at an older age, had the disease for a longer period and showed reduced esophageal distensibility at baseline predicted the need for future dilation in patients with strictures. The authors suggest that further studies that examine the disease from a molecular level could help them understand which patients may be at highest risk of severe disease and could benefit from a variety of treatment strategies. This study was supported by the National Institutes of Health grants R01DK124266-01, K23DK109263 and R21TR003039. Kennedy et al, 'Histologic response is associated with improved esophageal distensibility and symptom burden in pediatric eosinophilic esophagitis.' Gastroenterology. Online August 15, 2025. DOI: 10.1053/ About Children's Hospital of Philadelphia:A non-profit, charitable organization, Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, the hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country. The institution has a well-established history of providing advanced pediatric care close to home through its CHOP Care Network, which includes more than 50 primary care practices, specialty care and surgical centers, urgent care centers, and community hospital alliances throughout Pennsylvania and New Jersey. CHOP also operates the Middleman Family Pavilion and its dedicated pediatric emergency department in King of Prussia, the Behavioral Health and Crisis Center (including a 24/7 Crisis Response Center) and the Center for Advanced Behavioral Healthcare, a mental health outpatient facility. Its unique family-centered care and public service programs have brought Children's Hospital of Philadelphia recognition as a leading advocate for children and adolescents. For more information, visit ABOUT CHILDREN'S HOSPITAL COLORADO Children's Hospital Colorado is one of the nation's leading and most expansive nonprofit pediatric healthcare systems with a mission to improve the health of children through patient care, education, research and advocacy. Founded in 1908 and ranked among the best children's hospitals in the nation as recognized by U.S. News & World Report, Children's Colorado has established itself as a pioneer in the discovery of innovative and groundbreaking treatments that are shaping the future of pediatric healthcare worldwide. Children's Colorado offers a full spectrum of family-centered care at its urgent, emergency and specialty care locations throughout Colorado, including an academic medical center on the Anschutz Medical Campus in Aurora, hospitals in Colorado Springs, Highlands Ranch and Broomfield, and outreach clinics across the region. For more information, visit or connect with us on Facebook, Instagram and YouTube. Contact: Ben LeachChildren's Hospital of Philadelphia(609)634-7906leachb@
Malaysian Reserve
3 days ago
- Malaysian Reserve
LG LAUNCHES THE OPTIMISM METER TO HELP CANADIANS SPREAD POSITIVITY THROUGH MUSIC
LG invites Canadians to spread the Life's Good message by creating and sharing songs that bring optimism to others TORONTO, Aug. 15, 2025 /CNW/ – LG Electronics Canada, Inc. (LG Canada) wants to strike a chord with Canadians with the launch of the Optimism Meter – a new initiative designed to amplify and track the power of optimism. LG believes that choosing optimism makes Life Good and the Optimism Meter underscores this belief. Research shows a strong connection between music and positive emotions with more than 60% of participants in a recent survey identifying music as their most frequently used non-pharmacological cognitive enhancer.1 With this, LG invites Canadians to contribute to the Optimism Meter, and move the meter, by creating a personalized song, and sharing it with someone special using its new AI music tool, Radio Optimism. Every track shared with #OptimismWins, #LifesGood, and #RadioOptimism fuels the Optimism Meter and helps unlock a $25,000 donation to benefit the MLSE Foundation. 'Music isn't just background sound – it's one of the most powerful emotional tools we have. Whether we're trying to shake off a bad mood, calm our nerves, or tap into joy, people instinctively turn to music to regulate how they feel,' commented Dr. Frank A. Russo, Cognitive Neuroscientist and Director of the Science of Music, Auditory Research and Technology (SMART) Lab. 'It helps us understand our emotions and express what words can't. But perhaps just as important, music connects us to others. Singing or listening together can synchronize heart rates and even brain activity, fostering empathy and trust. Research has shown that music can reduce stress hormones like cortisol, boost bonding hormones like oxytocin, and make us feel closer – especially when we share a musical experience with others. At a neurological level, music activates the same reward circuits in the brain as food, and social connection. This might explain why surveys have consistently found that music is one of the most common non-prescription strategies for managing mood. Music helps us feel better, together.' A global study from LG reveals similar findings. In fact, one-third of Canadians polled believe sharing feelings through emotional content [such as music] and media is one of the most necessary ways to build meaningful connections and ultimately fuel optimism.2 This belief is supported by the understanding that having shared musical experiences, even when asynchronous, can allow people to appreciate their common humanity.3 Furthermore, the act of engaging with music together can release oxytocin, promoting social bonding.4 Radio Optimism transforms this concept into an interactive platform where participants can create and send personalized songs to their loved ones. Users can easily create new songs using AI-powered tools, which are thoroughly trained on a curated music dataset. These tools interpret user prompts to produce unique musical pieces and generate matching album art, providing an engaging and personalized experience. Once generated, these songs can be sent to recipients to deepen their connection and be shared online for others to discover worldwide. Canadians can participate in the Optimism Meter by: Sharing how music fuels their optimism on social media using #OptimismWins #LifesGood #RadioOptimism Creating and sharing personalized songs with Radio Optimism using #RadioOptimism #LifesGood #OptimismWins Visiting to learn more about the campaign and track the progress of the Optimism Meter. Every comment, post, and song shared with the campaign hashtags will contribute to the Optimism Meter, and unlock various milestones, culminating in a $25,000 donation to the MLSE Foundation. Focused on helping youth reach their full potential through sport, MLSE Foundation helps young people facing barriers thrive by providing free access to programs that support physical health, mental well-being, education, and career readiness. One standout program is the dance program at MLSE LaunchPad that empowers young girls through movement and music. With mentorship from North Side Crew, the Toronto Raptors dance team, and a recent showcase win, the program continues to inspire confidence, creativity, and connection. The Optimism Meter is more than just a campaign; it's an invitation to celebrate the joy of music, connect with others, and make a positive impact on communities across Canada. Together, let's spread the good vibes and show that Life's Good when #OptimismWins! Learn more and join the movement at About LG Electronics Canada, Inc. LG Electronics Canada, Inc. is the Canadian subsidiary of LG Electronics Inc., a global sales innovator in technology and manufacturing headquartered in Seoul, South Korea. LG Electronics Canada, with its head office in Toronto, Ontario, is comprised of three business units – Home Appliances Solution, Media Entertainment Solution, and Eco Solution. LG Electronics Canada is focused on delivering award-winning products known for blending style and technology. These innovative products include TVs, audio solutions and portable devices, home appliances, residential and commercial air solutions, computer monitors and laptops, and industry-leading OLED and LED digital display solutions. For more information, visit _______________________________________ 1 Soares, J. M., & Barbosa, M. (2024). The use of pharmacological and non-pharmacological cognitive enhancers in the Portuguese population. Performance Enhancement & Health, 12(1), 100274. 2 Focaldata, Fieldwork conducted from April 29 to May 1, 2025. Sample Size: 5,000 participants across US, UK, Australia, India and Canada, with 1,000 participants in each market, and nationally representative splits by age, gender and region. 3Good, A., Peets, K. F., Choma, B. L., & Russo, F. A. (2022). Singing foreign songs promotes shared common humanity in elementary school children. Journal of Applied Social Psychology, 52(12), 1158–1171. 4 Good, A., & Russo, F. A. (2022). Changes in mood, oxytocin, and cortisol following group and individual singing: A pilot study. Psychology of Music, 50(4), 1340–1347.
Malaysian Reserve
3 days ago
- Malaysian Reserve
In May, the Percentage of Patients with a Telehealth Claim Increased Nationally and in Every Region
Diabetes Entered Top Five Telehealth Diagnostic Categories in Midwest and West in May for First Time in 2025 NEW YORK, Aug. 15, 2025 /PRNewswire/ — In May 2025, the percentage of patients with a telehealth claim increased nationally and in all four US census regions, according to FAIR Health's Monthly Telehealth Regional Tracker. Nationally, that percentage increased from 14.2 percent of patients in April to 14.3 percent in May, a 0.8 percent rise. In May, the West had the largest share of patients with a telehealth claim, at 18.7 percent, and the Midwest had the smallest share, at 10.8 percent. The data represent the commercially insured population, excluding Medicare Fee-for-Service, Medicare Advantage and Medicaid. From April to May, changes in utilization as measured by telehealth claim lines1 varied. Nationally, telehealth claim lines fell from 5.01 percent of medical claim lines in April to 4.96 percent in May, a decrease of 1.0 percent. In the South, the decrease was 1.7 percent. In all other regions, there was an increase, from 0.4 percent in the West to 3.1 percent in the Northeast. Diagnostic Categories In May 2025, diabetes mellitus entered the top five telehealth diagnostic categories in the Midwest and West for the first time in 2025. In the Midwest, this diagnostic category entered in fifth position, displacing overweight and obesity; in the West, it entered in fourth position, displacing acute respiratory diseases and infections, which fell to the fifth rank, supplanting sleep disorders. In the South, diabetes fell off the list from fifth position, replaced by encounter for examination. In May, mental health conditions remained in first position nationally and in every region, though the percentage of patients with a telehealth claim for this diagnostic category decreased nationally and in all regions. Nationally, it fell from 63.0 percent in April to 62.1 percent in May. Urban versus Rural In May 2025, as in April, telehealth utilization was higher in urban than rural areas nationally and in every region.2 Nationally, 14.5 percent of patients in urban areas had a telehealth claim, compared to 7.5 percent in rural areas. The largest difference occurred in the West, where the percentage of urban patients using telehealth (18.8 percent) was 2.4 times the percentage of rural patients (7.9 percent). The smallest difference was found in the Northeast, where the percentage of patients in urban areas using telehealth (16.7 percent) was 1.5 times the percentage of patients in rural areas using telehealth (11.4 percent). Age Distribution In May 2025, as in April, the age groups 19-30 and 31-40 accounted for the largest percentages of patients with a telehealth claim nationally and in every region. Nationally in May, the age group 31-40 (22.8 percent) displaced the age group 19-30 (22.4 percent) as the age group with the largest percentage of patients having a telehealth claim. The same shift happened in the Northeast and South, though in the Midwest and West, the age group 19-30 still had the largest percentage of patients with a telehealth claim. Nationally and in every region, the age groups 0-9 and 65 and older accounted for the smallest shares (less than 10 percent each) of patients with a telehealth claim. Procedure Categories In May 2025, psychotherapy services and procedures, and established patient office or other outpatient services (including those for mental health conditions), were, as in April, the top two procedure categories nationally and in every region. The order of the two varied: In May, established patient office or other outpatient services ranked first nationally (at 47.7 percent of patients with a telehealth claim) and in the South and West, while psychotherapy services and procedures ranked first in the Midwest and Northeast. In April, established patient office or other outpatient services ranked second nationally (47.48 percent), while psychotherapy services and procedures (47.49 percent) ranked first. About the Monthly Telehealth Regional Tracker Launched in May 2020 as a free service, the Monthly Telehealth Regional Tracker uses FAIR Health data to track how telehealth is evolving from month to month. An interactive map of the four US census regions allows the user to view an infographic on telehealth in a specific month in the nation as a whole or in individual regions. Each year, the infographic introduces varied views into telehealth utilization. In this sixth iteration of the Monthly Telehealth Regional Tracker, each infographic shows month-to-month changes in telehealth utilization, both through telehealth's percentage of medical claim lines and percent of patients with a telehealth claim; that month's top five diagnostic categories; top five procedure categories; age distribution, which captures the percentage of patients within each age group with a telehealth claim; and urban versus rural telehealth usage. For the Monthly Telehealth Regional Tracker, click here. Follow us on X @FAIRHealth About FAIR Health FAIR Health is a national, independent nonprofit organization that qualifies as a public charity under section 501(c)(3) of the federal tax code. It is dedicated to bringing transparency to healthcare costs and health insurance information through data products, consumer resources and health systems research support. FAIR Health possesses the nation's largest collection of commercial healthcare claims data, which includes over 51 billion claim records and is growing at a rate of about 4 billion claim records a year. FAIR Health licenses its commercial data and data products—including benchmark modules, data visualizations, custom analytics and market indices—to commercial insurers and self-insurers, employers, providers, hospitals and healthcare systems, government agencies, researchers and others. Certified by the Centers for Medicare & Medicaid Services (CMS) as a national Qualified Entity, FAIR Health also receives data representing the experience of all individuals enrolled in traditional Medicare Parts A, B and D, which accounts for a separate collection of over 51 billion claim records; FAIR Health includes among the commercial claims data in its database, data on Medicare Advantage enrollees. FAIR Health can produce insightful analytic reports and data products based on combined Medicare and commercial claims data for government, providers, payors and other authorized users. FAIR Health's systems for processing and storing protected health information have earned HITRUST CSF certification and achieved AICPA SOC 2 Type 2 compliance by meeting the rigorous data security requirements of these standards. As a testament to the reliability and objectivity of FAIR Health data, the data have been incorporated in statutes and regulations around the country and designated as the official, neutral data source for a variety of state health programs, including workers' compensation and personal injury protection (PIP) programs. FAIR Health data serve as an official reference point in support of certain state balance billing laws that protect consumers against bills for surprise out-of-network and emergency services. FAIR Health also uses its database to power a free consumer website available in English and Spanish, which enables consumers to estimate and plan for their healthcare expenditures and offers a rich educational platform on health insurance. An English/Spanish mobile app offers the same educational platform in a concise format and links to the cost estimation tools. The website has been honored by the White House Summit on Smart Disclosure, the Agency for Healthcare Research and Quality (AHRQ), URAC, the eHealthcare Leadership Awards, appPicker, Employee Benefit News and Kiplinger's Personal Finance. For more information on FAIR Health, visit Contact:Rachel KentExecutive Director of Communications and MarketingFAIR Health646-396-0795rkent@ 1 A claim line is an individual service or procedure listed on an insurance claim.2 Each telehealth service was attributed to a rural/urban designation in a region based on the patient's medical service area, which FAIR Health determines based on the unique geographical pattern of services utilized by the patient.
